Future technology for breast cancer diagnosis is being tested in China
Breast cancer is the most common cancer among women: 1,600,000 breast cancers occur worldwide each year.
3D Ultrasound Computed Tomography (USCT) is an innovative medical diagnostic technology developed at KIT. It can image the breast in 3D with millimeter accuracy, taking into account tissue properties that were previously ignored in the search for tumors. Therefore, USCT promises high sensitivity and specificity for breast cancer diagnosis, ie tumors are detected reliably. “In the long term, USCT technology could be widely used in everyday medical practice,” says Nicole Ruiter, who leads the research team at the KIT’s Institute for Process Data Processing and Electronics, which developed the technology: “USCT is as cost-effective as mammography and can be used as often as and to be used in young women,
A prototype is currently being tested in Germany in a second study. With Chinese industry partners, further USCT systems with optimized image quality and improved ultrasound transducers are being developed, which will then be tested as part of a large multi-center study involving more than 1,000 patients in the People’s Republic of China. From the study, the scientists of KIT and their partners hope to obtain representative statistical data on the diagnostic quality of the device. At the same time, medical approval is being prepared in China. Breast cancer is the most common cancer in women.
source: Karlsruhe Institute of Technology